Technologie efficace de synthèse de peptides basée sur des études de production chimique covalente dynamique

Technologie efficace de synthèse de peptides basée sur des études de production chimique covalente dynamique

Background and Challenges

Since the first peptide gly-gly was synthesized in 1901, peptide synthesis has undergone more than 100 years of development, and as an important participant in life activities, it has shown great potential in the fields of drug discovery and development, biomaterials, and cosmetics. Traditional peptide synthesis methods are inefficient, costly, and environmentally polluting, which seriously restrict their wide application. The development of efficient, green and economical peptide synthesis technology has become an urgent challenge. Here, based on the theoretical foundation of scientific research, we apply the theory to practice and successfully realize the application of catalytic peptide synthesis technology in actual production.


Technological breakthrough

Bifunctional organic small molecule catalyst: Using thiourea-tertiary amine synergistic catalysis, we successfully avoided the involvement of metal and realized the green coupling technology without metal.

  • Unique reaction mechanism: tertiary amine pulls hydrogen to improve the nucleophilicity of amino group, and thiourea’s rigid structure realizes the function of capturing the amino group, thus realizing the fixed-point catalysis.
  • Significantly improved coupling efficiency: the coupling efficiency of a single step under liquid phase conditions has been shortened to 5 minutes, and the coupling efficiency is as high as 99%.
  • Green chemistry technology: water/ionic liquid system replaces DMF to reduce organic waste emission, and the by-product is only water, simple post-processing, and suitable for continuous flow reactor, realizing continuous peptide synthesis on the scale of kilograms.

Conclusion

The thiourea-tertiary amine co-catalyzed peptide synthesis technology can rapidly construct peptide libraries for high-throughput screening, significantly shorten the R&D cycle of anticancer and antiviral drugs, support the large-scale production of complex peptides, and promote more peptide drugs to enter into the clinical research. It reduces the use of reagents and solvents, and successfully lowers the cost of peptide synthesis, and can rapidly realize the large-scale synthesis of peptides.

administrateur Avatar

Zejun Peng

Directeur de la technologie; Expert en synthèse peptidique Expertise de base: Synthèse peptidique complexe, modifications non naturelles des acides aminés, et la construction de peptides cycliques et de peptides agrafés.

Biographie:Zejun Peng possède une vaste expérience en chimie organique et en synthèse peptidique. Il maîtrise l'application combinée de la synthèse peptidique en phase solide (SPSS) et synthèse peptidique en phase liquide (LPPS), et est particulièrement doué pour surmonter les « séquences extrêmement difficiles à synthétiser » (comme les peptides à chaîne ultra longue, séquences hautement hydrophobes, et repliement de liaisons disulfure multiples). Sous sa direction, l'équipe a réussi à surmonter les goulots d'étranglement techniques dans plusieurs modifications spécialisées (comme la N-méthylation, PEGylation, et étiquetage fluorescent), maintenir un taux de réussite de synthèse supérieur à 98%.

Fait vérifié & Directives éditoriales
Révisé par: Experts en la matière
Partagez cet article
Maison Recherche WhatsApp Services Produit